Yourgene Health PLC chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.05
Dividend & YieldN/A£ (N/A)
Beta 0.95
Market capitalization 27.27M
Operating cash flow 1.31M
ESG Scores unknown

Company description

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.

Sector: Healthcare - Industry: Diagnostics & Research

Financial Ratios
Quick Ratio1.46
Working Capital-1.75
Return On Equity-0.37
Debt To Equity0
Fixed Asset Ratio0.34
Fixed Interest Cover-20.71

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities 1.03M -1.29M -34k 3.01M
Total Cashflows From Investing Activities -590.76k -9.03M -7.45M -3.48M
Net Borrowings -4.01M -561.86k -480k 4.06M
Total Cash From Financing Activities 5.61M 12.62M 15.5M 3.61M
Change To Operating Activities
Issuance Of Stock 9.85M 14.33M 17.25M 55k
Net Income 3.39M -2.43M -12.18M -1.92M
Change In Cash 967.93k 1.51M 4.23M 1.43M
Effect Of Exchange Rate
Total Cash From Operating Activities -4.05M -2.07M -3.82M 1.31M
Depreciation 1.1M 1.91M 2.7M 3.75M
Change To Account Receivables -910.66k -1.17M 646k -1.66M
Other Cashflows From Financing Activities -236.76k -1.15M -1.28M -508k
Change To Netincome -8.2M 698.92k 6.03M 221k
Capital Expenditures -1.07M -617.09k -3M -2.33M

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development
Income Before Tax 3.39M -3.38M -12.01M -3.19M
Net Income 3.39M -2.43M -12.18M -1.92M
Selling General Administrative 8.32M 10.64M 14.44M 18.28M
Gross Profit 4.61M 10.22M 11.38M 21.36M
Ebit -4.78M -2.44M -6.25M -1.5M
Operating Income -4.78M -2.44M -6.25M -1.5M
Interest Expense -1.25M -163.2k -302k -656k
Income Tax Expense 491 -948.19k 175k -1.27M
Total Revenue 8.88M 16.61M 18.29M 37.56M
Cost Of Revenue 4.27M 6.39M 6.91M 16.2M
Total Other Income ExpenseNet 8.17M -941.27k -5.76M -1.7M
Net Income From Continuing Ops 3.39M -2.43M -12.18M -1.92M
Net Income Applicable To Common Shares 3.39M -2.43M -12.18M -1.92M

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 4.9M 11.38M 16.2M 31.32M
Total Stockholder Equity 10.7M 26.3M 32.92M 32.74M
Other Current Liabilities 1.39M 2.4M 3.21M 947k
Total Assets 15.6M 37.68M 49.13M 64.06M
Common Stock 32.4M 32.56M 32.67M 32.67M
Other Current Assets
Retained Earnings -32.66M -33.49M -44.88M -46.59M
Treasury Stock -27.01M -23.95M -22.13M -21.12M
Cash 1.25M 2.76M 7M 8.43M
Total Current Liabilities 4.25M 6.47M 8.77M 12.25M
Other Stockholder Equity -27.01M -23.95M -22.13M -21.12M
Property, Plant, and Equipment 2.05M 4.88M 8.26M 18.13M
Total Current Assets 5.3M 10M 15.73M 21.74M
Net Tangible Assets 2.45M 5.66M 9.93M 11.97M
Net Receivables 2.92M 5.5M 4.99M 5.93M
Accounts Payable 2.09M 2.67M 3.12M 4.33M


Insider Transactions

Here are the insider transactions of stock shares related to Yourgene Health PLC:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Rees (Lyn Dafydd)Bought at price 0.09 per share.D2022-05-111M
Jeffreys (Hayden)Bought at price 0.10 per share.D2022-03-21355.45k
Hextall (Barry)Bought at price 0.16 per share.D2022-01-2152.09k
Hextall (Barry)Sold at price 0.16 per share.D2022-01-211.76k
Life Technologies, Ltd.D2021-08-05
Myers (Steven)D2021-08-05
TB Amati UK Smaller Companies FundD2021-08-05
Business Growth Fund PlcD2021-08-05
Chang (Bill)D2021-08-05
Myers (Steven)D2021-06-295.17M
Chang (Bill)D2021-05-21510k
Chang (Bill)D2021-03-31
Mustoe (Nicholas)D2021-03-31
Rees (Lyn Dafydd)D2021-03-31
Reynolds (Adam)D2021-03-31
Hextall (Barry)D2021-03-31
Jeffreys (Hayden)D2021-03-31
Little (Stephen)D2021-03-31
Mason (Joanne)D2021-03-31
Brown (John)D2021-03-31
Intuitive Investments Group PLCBought at price 0.23 per share.D2021-02-221.58M
Brown (John)Bought at price 0.17 per share.D2021-02-09102.45k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Yourgene Health PLC. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Yourgene Health PLC

Here is the result of two systematic investment strategies applied to Yourgene Health PLC. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Yourgene Health PLC

The following chart shows the equity curve of the two systematic investment strategies applied to Yourgene Health PLC:

Yourgene Health PLC automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 6350.94% on the backtest period.

Performance at glance

Performance

6350.94 %

Latent gain

143336.07 £

Invested capital

2256.93 £

Annualized return

1534.04 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Yourgene Health PLC

This is the result of two momentum investment strategies applied to Yourgene Health PLC. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Yourgene Health PLC

The following chart shows all the entries opened by the momentum investment system on Yourgene Health PLC:

Yourgene Health PLC momentum entries
  • The first momentum investment strategy would give 2811789.87% of return on Yourgene Health PLC. That represents 63090378.82£ of latent gain with 2243.78£ of employed capital.
  • The second momentum investment strategy would give 7945.61% of return on Yourgene Health PLC. That represents 98912.53£ of latent gain with 1244.87£ of employed capital.
Performance at glance (1Q Momentum)

Performance

2811789.87 %

Latent gain

63090378.82 £

Invested capital

2243.78 £

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

7945.61 %

Latent gain

98912.53 £

Invested capital

1244.87 £

Annualized return

2170.93 %

Momentum equity curve on Yourgene Health PLC

The following chart shows the equity curve of the two momentum strategies applied to Yourgene Health PLC:

Yourgene Health PLC momentum equity

Note: the dividends potentially given by Yourgene Health PLC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Yourgene Health PLC

The following chart shows the employed capital evolution of the two momentum strategies on Yourgene Health PLC since the beginning:

Yourgene Health PLC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on Yourgene Health PLC

Buy the dip entry openings on Yourgene Health PLC

Yourgene Health PLC

The performance achieved by the robo-advisor on Yourgene Health PLC is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows Yourgene Health PLC stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Yourgene Health PLC, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

0.0 %

Equity curve of the strategy applied to Yourgene Health PLC

The following chart shows the result of the investment strategy applied to Yourgene Health PLC:

Yourgene Health PLC

Note: the dividends potentially given by Yourgene Health PLC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Yourgene Health PLC

The following chart shows the employed capital evolution since the beginning of the investment strategy on Yourgene Health PLC:

Yourgene Health PLC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Yourgene Health PLC

In this section, I will compare the three previous investment strategies applied to Yourgene Health PLC.

Equity curve comparison on Yourgene Health PLC

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Yourgene Health PLC investment strategy comparison

Employed capital comparison on Yourgene Health PLC

Yourgene Health PLC investment comparison

Performance comparison on Yourgene Health PLC

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 6350.94% 143336.07£ 2256.93£ 1534.04%
Momentum 1 quarter 2811789.87% 63090378.82£ 2243.78£ 720971.76%
Momentum 2 quarters 7945.61% 98912.53£ 1244.87£ 2170.93%
Non-directional 0% 0.0£ 0.0£ 0.0%
Annualized return comparison

Automatic investment

1534.04 %

Momentum 1Q

2170.93 %

Momentum 2Q

2170.93 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Yourgene Health PLC:

Positive correlations

Most correlated stocks this year

  • Yourgene Health PLC

  • Most correlated stocks last 3 months

  • Yourgene Health PLC
  • CH BEIDAHUANG
  • CHI P ENERGY
  • RENRUI HR

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • ShockWave Medical Inc
  • East Stone Acquisition Corp

  • Note: The algorithm computes the probability of correlation between Yourgene Health PLC and the other stocks. There may be false positives or some missing correlated stocks. If the price of Yourgene Health PLC does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Yourgene Health PLC
    Country United Kingdom
    City Manchester
    Address Skelton House
    Phone 44 16 1669 8122
    Website www.yourgene-health.com
    FullTime employees 253
    Industry Diagnostics & Research
    Sector Healthcare
    Exchange XLON
    Ticker YGEN.XLON
    Market www.londonstockexchange.com

    Yourgene Health PLC ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown